These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13300049)

  • 1. [The treatment of prostate carcinoma with depot-dienol forte].
    BUCHER A
    Wien Med Wochenschr; 1955 Dec; 105(48):1006-7. PubMed ID: 13300049
    [No Abstract]   [Full Text] [Related]  

  • 2. TACE in the treatment of carcinoma of the prostate: an 80-month survey.
    CARROLL G; BRENNAN RV
    J Urol; 1958 Aug; 80(2):155-7. PubMed ID: 13564606
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mammary carcinoma after stilbene treatment of a prostate carcinoma].
    KELLER J
    Z Arztl Fortbild (Jena); 1953 Aug; 47(16):584-6. PubMed ID: 13103170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of prostate carcinoma].
    MULLER F
    Rozhl Chir; 1958 Feb; 35(1):53-7. PubMed ID: 13467023
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine therapy in carcinoma of the prostate.
    CARROLL G; BRENNAN RV
    J Am Med Assoc; 1955 Feb; 157(7):581-3. PubMed ID: 13232979
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recurrent lung metastases in prostate carcinoma and Cyren A implantation].
    LANGE
    Z Urol; 1953; 46(5):333-6. PubMed ID: 13103625
    [No Abstract]   [Full Text] [Related]  

  • 7. TACE in the endocrine management of prostatic carcinoma.
    HEADSTREAM JW; ALLEN DO; JONES BW
    J Am Geriatr Soc; 1957 Apr; 5(4):453-5. PubMed ID: 13428532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estrogen therapy of prostate cancer].
    OBERHOLTZER A
    Minerva Urol; 1956; 8(4):127-35. PubMed ID: 13369344
    [No Abstract]   [Full Text] [Related]  

  • 9. TACE in prostatic cancer: clinical and biochemical considerations.
    CARROLL G; BRENNAN RV
    J Urol; 1954 Sep; 72(3):497-503. PubMed ID: 13202238
    [No Abstract]   [Full Text] [Related]  

  • 10. [New advances in hormonal treatment of prostate cancer; the use of chlorotrianisene].
    RAVINA A
    Presse Med (1893); 1955 Sep; 63(59):1198. PubMed ID: 13266742
    [No Abstract]   [Full Text] [Related]  

  • 11. [New treatments for cancer of the prostate].
    AMIEL C
    Vie Med; 1959 Apr; 40(4):337 passim. PubMed ID: 13659813
    [No Abstract]   [Full Text] [Related]  

  • 12. TACE in the treatment of carcinoma of the prostate: an 80-month surgery.
    CARROLL G; BRENNAN RV
    Trans South Cent Sect Am Urol Assoc; 1957; 52():64-6. PubMed ID: 13556886
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with combined hormonal treatment of prostate carcinoma].
    PECHERSTORFER M
    Wien Med Wochenschr; 1959 Feb; 109(6):133-4. PubMed ID: 13648373
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine-control therapy in prostatic cancer.
    FERGUSSON JD
    Br J Urol; 1958 Dec; 30(4):397-406; discussion 411-4. PubMed ID: 13608018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resveratrol and newly synthetized resveratrol analogs in therapy of prostate carcinoma].
    Djavan B; Marihart S; Kuehhas F; Rom M; Partin A; Schalken J; Sekeres T
    Urologe A; 2007 Sep; 46(9):1101-3. PubMed ID: 17690863
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)].
    HERBEUVAL R; GUILLEMIN P; CUNY G; LARCAN A; BESSOT M
    J Urol Medicale Chir; 1957 Jun; 63(6):422-6. PubMed ID: 13476487
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modern trends in the treatment of cancer of the prostate: phosphorylated estrogens].
    CHIEREGO F; FABRIS P
    G Ital Chemioter; 1956; 3(3-4):569-71. PubMed ID: 13462210
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of prostate cancer with phosphorylated estrogens (estrol diphosphate)].
    CHIEREGO F; FABRIS P
    Arch Ital Urol; 1956; 29(5):357-83. PubMed ID: 13395753
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormono- therapy of cancer of the prostate].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():181-91. PubMed ID: 5485068
    [No Abstract]   [Full Text] [Related]  

  • 20. Histological changes in carcinomatous prostate treated with phosphorylated estrogen.
    FABRIS P; CHIEREGO F
    Minerva Urol; 1957; 9(3):109-10. PubMed ID: 13493272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.